AR039166A1 - Composiciones de venlafaxina base - Google Patents
Composiciones de venlafaxina baseInfo
- Publication number
- AR039166A1 AR039166A1 ARP030101074A ARP030101074A AR039166A1 AR 039166 A1 AR039166 A1 AR 039166A1 AR P030101074 A ARP030101074 A AR P030101074A AR P030101074 A ARP030101074 A AR P030101074A AR 039166 A1 AR039166 A1 AR 039166A1
- Authority
- AR
- Argentina
- Prior art keywords
- venlafaxine
- base
- compositions
- liquid phase
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Composición farmacéutica que comprende una venlafaxina base sólida y un excipiente farmacéuticamente aceptable, a un procedimiento para preparar una composición de venlafaxina, que comprende dispersar venlafaxina base en un portador de fase líquida; y solidificar dicha fase líquida para formar una dispersión sólida de venlafaxina, y al uso de una composición farmacéutica como un medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36773602P | 2002-03-28 | 2002-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR039166A1 true AR039166A1 (es) | 2005-02-09 |
Family
ID=28675392
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101073A AR039165A1 (es) | 2002-03-28 | 2003-03-27 | Venlafaxina base |
ARP030101074A AR039166A1 (es) | 2002-03-28 | 2003-03-27 | Composiciones de venlafaxina base |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101073A AR039165A1 (es) | 2002-03-28 | 2003-03-27 | Venlafaxina base |
Country Status (5)
Country | Link |
---|---|
US (2) | US20030190352A1 (es) |
EP (1) | EP1487429A2 (es) |
AR (2) | AR039165A1 (es) |
AU (2) | AU2003226748A1 (es) |
WO (2) | WO2003082806A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060246132A1 (en) * | 2003-02-07 | 2006-11-02 | Fjalar Johannsson | Sustained release formulations of venlafaxine |
US20050048118A1 (en) * | 2003-07-25 | 2005-03-03 | Joan Cucala Escoi | Modified release venlafaxine hydrochloride tablets |
EP1523979A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release pharmaceutical dosage form |
US20050142203A1 (en) * | 2003-12-30 | 2005-06-30 | Grant Heinicke | Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same |
DE602004006443T2 (de) * | 2004-02-04 | 2008-01-10 | Alembic Ltd., Vadodara | Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung |
JP2007520553A (ja) * | 2004-02-06 | 2007-07-26 | ワイス | 多微粒子o−デスメチルベンラファキシン塩およびその使用 |
ATE554752T1 (de) | 2004-02-06 | 2012-05-15 | Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust | Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom |
AU2004319799A1 (en) * | 2004-05-21 | 2005-12-01 | Lupin Ltd. | Novel extended release composition of Venlafaxine hydrochloride containing polyvinyl acetate |
JP5009152B2 (ja) * | 2004-05-28 | 2012-08-22 | サリックス ファーマシューティカルズ, インコーポレイテッド | 放射線誘発性腸炎の予防、処置、および回復 |
CN1955159B (zh) | 2005-06-17 | 2010-11-24 | 山东绿叶制药有限公司 | 用于阻断5-羟色胺以及去甲基肾上腺素再摄取的化合物,其制备方法及其用途 |
WO2007011619A2 (en) * | 2005-07-15 | 2007-01-25 | Wyeth | Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
EP2529729A1 (en) * | 2005-08-24 | 2012-12-05 | Salix Pharmaceuticals, Inc. | Balsalazide formulations and manufacture thereof |
CN102212014B (zh) * | 2010-04-09 | 2013-12-25 | 江苏豪森医药集团有限公司 | O-去甲基-文拉法辛的谷氨酸盐的晶型、其制备方法及其在医药上的应用 |
US20130034604A1 (en) * | 2010-05-14 | 2013-02-07 | Alembic Pharmaceuticals Limited | Extended release formulations of desvenlafaxine base |
CA2860747C (en) | 2010-10-01 | 2015-08-11 | Shan Dong Luye Pharmaceutical Co., Ltd. | Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
GB8902209D0 (en) * | 1989-02-01 | 1989-03-22 | Wyeth John And Brother Limited | Preparation of cyclohexanol derivatives and novel thioamide intermediates |
DE69429895T2 (de) * | 1993-06-28 | 2002-08-29 | American Home Products Corp., Madison | Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
US20020022662A1 (en) * | 1999-06-15 | 2002-02-21 | American Home Products Corporation | Enantiomers of O-desmethyl venlafaxine |
YU43702A (sh) * | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka |
US20020183553A1 (en) * | 2000-10-19 | 2002-12-05 | Ben-Zion Dolitzky | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
SK5762003A3 (en) * | 2000-10-19 | 2003-11-04 | Teva Pharma | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
BR0100334A (pt) * | 2001-01-17 | 2002-09-24 | Diffucap Chemobras Quimica E F | Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante |
-
2003
- 2003-03-27 WO PCT/EP2003/003320 patent/WO2003082806A1/en not_active Application Discontinuation
- 2003-03-27 AU AU2003226748A patent/AU2003226748A1/en not_active Abandoned
- 2003-03-27 EP EP03745289A patent/EP1487429A2/en not_active Withdrawn
- 2003-03-27 US US10/397,353 patent/US20030190352A1/en not_active Abandoned
- 2003-03-27 US US10/397,381 patent/US20030191347A1/en not_active Abandoned
- 2003-03-27 AR ARP030101073A patent/AR039165A1/es unknown
- 2003-03-27 AU AU2003226752A patent/AU2003226752A1/en not_active Abandoned
- 2003-03-27 AR ARP030101074A patent/AR039166A1/es unknown
- 2003-03-27 WO PCT/EP2003/003311 patent/WO2003082262A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003082806A1 (en) | 2003-10-09 |
US20030190352A1 (en) | 2003-10-09 |
AU2003226748A8 (en) | 2003-10-13 |
AU2003226752A1 (en) | 2003-10-13 |
WO2003082262A2 (en) | 2003-10-09 |
WO2003082262A3 (en) | 2004-07-29 |
AR039165A1 (es) | 2005-02-09 |
US20030191347A1 (en) | 2003-10-09 |
EP1487429A2 (en) | 2004-12-22 |
AU2003226748A1 (en) | 2003-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR039166A1 (es) | Composiciones de venlafaxina base | |
CL2004001267A1 (es) | Compuestos derivados de quinazolina, inhibidor de quinasa; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para preparar un medicamento para tratar trastornos proliferativos celulares tales como ateroesclerosis, | |
UY31406A1 (es) | "producto de dispersion solida que contiene un compuesto a base de n-aril urea". | |
RS51569B (en) | COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL | |
BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
CL2009001766A1 (es) | Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica. | |
BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
WO2010041141A3 (en) | Oil-based foamable carriers and formulations | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
TW200607798A (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
AR007827A1 (es) | 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos. | |
TW200633964A (en) | Tetralin and indane derivatives and uses thereof | |
BR0211601A (pt) | Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos | |
UY29896A1 (es) | Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
AR034813A1 (es) | Composiciones farmaceuticas y uso de las mismas | |
MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
NO20042158L (no) | Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme | |
ATE499939T1 (de) | Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend | |
AR027360A1 (es) | Composicion farmaceutica | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
CL2009000980A1 (es) | Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006). | |
PL1868631T3 (pl) | Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej | |
AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
TW200505436A (en) | Modified release pharmaceutical compositions and the processes for preparing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |